Status:
UNKNOWN
Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
Lead Sponsor:
Renmin Hospital of Wuhan University
Conditions:
Gastrointestinal Disease
Endoscopy
Eligibility:
All Genders
18+ years
Brief Summary
In this study, the investigators proposed a prospective study about the effectiveness of artificial intelligence system for Retrograde cholangiopancreatography. The subjects would be include in an ana...
Detailed Description
Endoscopy is a routine and reliable method for the diagnosis of digestive tract diseases.Common endoscopy are gastroscopy, colonoscopy, capsule endoscopy and enteroscopy, ultrasonic gastroscopy, after...
Eligibility Criteria
Inclusion
- Who needs ERCP and its related tests are needed to further define the characteristics of digestive tract diseases
- Able to read, understand and sign informed consent
- The investigator believes that the subject can understand the process of the clinical study, is willing and able to complete all the study procedures and follow-up visits, and cooperate with the study procedures
- Patients with a natural duodenal papilla
Exclusion
- Has participated in other clinical trials, signed informed consent and is in the follow-up period of other clinical trials
- Has drug or alcohol abuse or mental disorder in the last 5 years
- Women who are pregnant or lactating
- Subjects with previous biliary sphincterotomy
- The investigator determined that subjects were not suitable for ERCP and related tests
- A high-risk disease or other special condition that the investigator considers inappropriate for the subject to participate in a clinical trial
- Patients with known more severe pancreatic head carcinoma
- Patients with acute pancreatitis within 3 days
- Biliary stent replacement or removal did not occur after pancreatic angiography as expected
- Acute cardiovascular and cerebrovascular diseases
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04719117
Start Date
September 1 2020
End Date
December 31 2021
Last Update
January 22 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Renmin hospital
Wuhan, Hubei, China, 430000
2
People's Hospital
Shanghai, Shanghai Municipality, China, 200072
3
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433